3 research outputs found
The impact of the COVID-19 pandemic in diabetes and dyslipidemia management in a Spanish region: a retrospective study of the Aragon population
IntroductionPrevious research has indicated that the COVID-19 outbreak had a negative impact on the diagnosis and management of cardiometabolic diseases. Our aim was to analyze the impact of the COVID-19 pandemic on the management of dyslipidemia and type 2 diabetes (T2D) in the Aragon region of Spain.MethodsWe conducted an observational retrospective study, which included data from all patients diagnosed with active T2D or dyslipidemia in Aragon during 2019â2021. Data was collected from the BIGAN platform, a big database that includes all healthcare data from the Aragon population. Clinical, biochemical, and pharmacological prescription information was obtained for each patient and for each year.ResultsOut of the total population of 1,330,000 in the Aragon region, 90,000 subjects were diagnosed with T2D each year, resulting in a prevalence of approximately 7%. The COVID-19 pandemic resulted in a decrease in the prevalence of this disease and a lower incidence during the year 2020. In addition, patients with T2D experienced a deterioration of their glucose profile, which led to an increase in the number of patients requiring pharmacological therapy. The prevalence of dyslipidemia was approximately 23.5% in both 2019 and 2020 and increased to 24.5% in 2021. Despite the worsening of the anthropometric profile, the lipid profile improved significantly throughout 2020 and 2021 compared to 2019. Moreover, the number of active pharmacological prescriptions increased significantly in 2021.DiscussionOur findings suggest that the overload of the health system caused by the COVID-19 pandemic has resulted in an underdiagnosis of T2D. Moreover, patients with T2D experienced a worsening of their glycemic profile, an increase in their pharmacological requirements, and lower performance of their analytical determinations. Dyslipidemic subjects improved their lipid profile although the value of lipid profile determination decreased between 2020 and 2021
Effectiveness of an mHealth Intervention Combining a Smartphone App and Smart Band on Body Composition in an Overweight and Obese Population: Randomized Controlled Trial (EVIDENT 3 Study)
[EN]Background: Mobile health (mHealth) is currently among the supporting elements that may contribute to an improvement in
health markers by helping people adopt healthier lifestyles. mHealth interventions have been widely reported to achieve greater
weight loss than other approaches, but their effect on body composition remains unclear.
Objective: This study aimed to assess the short-term (3 months) effectiveness of a mobile app and a smart band for losing
weight and changing body composition in sedentary Spanish adults who are overweight or obese.
Methods: A randomized controlled, multicenter clinical trial was conducted involving the participation of 440 subjects from
primary care centers, with 231 subjects in the intervention group (IG; counselling with smartphone app and smart band) and 209
in the control group (CG; counselling only). Both groups were counselled about healthy diet and physical activity. For the 3-month
intervention period, the IG was trained to use a smartphone app that involved self-monitoring and tailored feedback, as well as
a smart band that recorded daily physical activity (Mi Band 2, Xiaomi). Body composition was measured using the InBody 230
bioimpedance device (InBody Co., Ltd), and physical activity was measured using the International Physical Activity Questionnaire. Results: The mHealth intervention produced a greater loss of body weight (â1.97 kg, 95% CI â2.39 to â1.54) relative to standard
counselling at 3 months (â1.13 kg, 95% CI â1.56 to â0.69). Comparing groups, the IG achieved a weight loss of 0.84 kg more
than the CG at 3 months. The IG showed a decrease in body fat mass (BFM; â1.84 kg, 95% CI â2.48 to â1.20), percentage of
body fat (PBF; â1.22%, 95% CI â1.82% to 0.62%), and BMI (â0.77 kg/m2, 95% CI â0.96 to 0.57). No significant changes were
observed in any of these parameters in men; among women, there was a significant decrease in BMI in the IG compared with the
CG. When subjects were grouped according to baseline BMI, the overweight group experienced a change in BFM of â1.18 kg
(95% CI â2.30 to â0.06) and BMI of â0.47 kg/m2 (95% CI â0.80 to â0.13), whereas the obese group only experienced a change
in BMI of â0.53 kg/m2 (95% CI â0.86 to â0.19). When the data were analyzed according to physical activity, the moderate-vigorous
physical activity group showed significant changes in BFM of â1.03 kg (95% CI â1.74 to â0.33), PBF of â0.76% (95% CI â1.32%
to â0.20%), and BMI of â0.5 kg/m2 (95% CI â0.83 to â0.19).
Conclusions: The results from this multicenter, randomized controlled clinical trial study show that compared with standard
counselling alone, adding a self-reported app and a smart band obtained beneficial results in terms of weight loss and a reduction
in BFM and PBF in female subjects with a BMI less than 30 kg/m2 and a moderate-vigorous physical activity level. Nevertheless,
further studies are needed to ensure that this profile benefits more than others from this intervention and to investigate modifications
of this intervention to achieve a global effect.[EN]This study was funded by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, and co-funded by the
European Union (ERDF/ESF, âInvesting in your futureâ) (RD12/0005/0001, RD16/0007/0003, RD16/0007/0005, RD16/0007/0008,
RD16/0007/0009 and PI16/00101, PI16/00952, PI16/00765, PI16/00659, PI16/00421, PI16/00170, FI17/00040). Gerencia
Regional de Salud de Castilla y Leon (GRS 1277/B/16) also collaborated in the funding of this study. They played no role in the
study design, data analysis, reporting results, or decision to submit the manuscript for publication
Long-term Effectiveness of a Smartphone App Combined With a Smart Band on Weight Loss, Physical Activity, and Caloric Intake in a Population With Overweight and Obesity (Evident 3 Study): Randomized Controlled Trial
[EN]Background: Multicomponent mobile health approaches can improve lifestyle intervention results, although little is known
about their long-term effectiveness.
Objective: This study aims to evaluate the long-term effectiveness (12 months) of a multicomponent mobile health
interventionâcombining a smartphone app, an activity tracker wristband, and brief counseling, compared with a brief counseling
group onlyâon weight loss and improving body composition, physical activity, and caloric intake in Spanish sedentary adults
with overweight or obesity.
Methods: We conducted a randomized controlled, multicenter clinical trial (Evident 3). A total of 650 participants were recruited
from 5 primary care centers, with 318 participants in the intervention group (IG) and 332 in the control group (CG). All participants
were briefly counseled about a healthy diet and physical activity at the baseline visit. For the 3-month intervention period, the
IG received training to use the app to promote healthy lifestyles and the smart band (Mi Band 2, Xiaomi). All measurements were
performed at baseline and at 3 and 12 months. Physical activity was measured using the International Physical Activity QuestionnaireâShort Form. Nutritional habits were assessed using the Food Frequency Questionnaire and Adherence to
Mediterranean diet questionnaire.
Results: Of the 650 participants included, 563 (86.6%) completed the 3-month visit and 443 (68.2%) completed the 12-month
visit. After 12 months, the IG showed net differences in weight (â0.26, 95% CI â1.21 to 0.70 kg; P=.02), BMI (â0.06, 95% CI
â0.41 to 0.28 points; P=.01), waist-height ratio (â0.25, 95% CI â0.94 to 0.44; P=.03), body adiposity index (â0.33, 95% CI â0.77
to 0.11; P=.03), waist circumference (â0.48, 95% CI â1.62 to 0.66 cm, P=.04) and hip circumference (â0.69, 95% CI â1.62 to
0.25 cm; P=.03). Both groups lowered daily caloric intake and increased adherence to the Mediterranean diet, with no differences
between the groups. The IG increased light physical activity time (32.6, 95% CI â30.3 to 95.04 min/week; P=.02) compared with
the CG. Analyses by subgroup showed changes in body composition variables in women, people aged >50 years, and married
people.
Conclusions: The low-intensity intervention of the Evident 3 study showed, in the IG, benefits in weight loss, some body
composition variables, and time spent in light physical activity compared with the CG at 3 months, but once the devices were
collected, the downward trend was not maintained at the 12-month follow-up. No differences in nutritional outcomes were
observed between the groups.This study was funded by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III and cofunded by the
European Union (ERDF/ESF, âInvesting in your futureâ; RD16/0007/0003, RD16/0007/0005, RD16/0007/0008, and
RD16/0007/0009; and PI16/00101, PI16/00952, PI16/00765, PI16/00659, PI16/00421, PI16/00170, and FI17/00040; REDIAPP).
Gerencia Regional de Salud de Castilla y Leon (GRS 1277/B/16 and GRS 1580/B/17) also collaborated with the funding of this
study. They played no role in the study design, data analysis, reporting results, or the decision to submit the manuscript for
publication